Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nextremity Solutions is a U.S. orthopedic medical device company focused on extremity musculoskeletal products, particularly foot and ankle implants and procedure-ready sterile systems. The company developed and commercialized indication-specific technologies for fractures, deformities, fusions, and other forefoot surgical applications in the lower and upper extremities. Its portfolio has included systems such as the Stratum Foot Plating System and Stratum Ankle Fusion Plating System, built around proprietary implant and instrumentation designs intended to improve surgical precision and workflow. Founded in Warsaw, Indiana, Nextremity built in-house R&D and manufacturing capabilities and operated as a strategic commercialization organization in orthopedics. In May 2022, the company was acquired by Medartis, which integrated Nextremity into its U.S. extremities business while retaining the Warsaw site as a manufacturing and R&D base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nextremity Solutions.